Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[18F]FDG PET/CT in Short-Term Complications of COVID-19: Metabolic Markers of Persistent Inflammation and Impaired Respiratory Function.
Triviño-Ibáñez EM, Jiménez-Rodríguez BM, Rudolphi-Solero T, García-Rivero EY, Rodríguez-Fernández A, Llamas-Elvira JM, Gómez-Río M, Morales-García C. Triviño-Ibáñez EM, et al. Among authors: morales garcia c. Diagnostics (Basel). 2022 Mar 29;12(4):835. doi: 10.3390/diagnostics12040835. Diagnostics (Basel). 2022. PMID: 35453883 Free PMC article.
On the single and multiple associations of COVID-19 post-acute sequelae: 6-month prospective cohort study.
Jiménez-Rodríguez BM, Gutiérrez-Fernández J, Ramos-Urbina EM, Romero-Ortiz AD, García-Flores PI, Santiago-Puertas MI, Martín-López MJ, López-Milena G, Fabregas R, Morales-García C. Jiménez-Rodríguez BM, et al. Among authors: morales garcia c. Sci Rep. 2022 Mar 1;12(1):3402. doi: 10.1038/s41598-022-07433-8. Sci Rep. 2022. PMID: 35233062 Free PMC article.
Abnormal Alpha-1 Antitrypsin Levels and Other Risk Factors Associated with Lung Function Impairment at 6 and 12 Months after Hospitalization Due to COVID-19: A Cohort Study.
Jiménez-Rodríguez BM, Triviño-Ibáñez EM, Gutiérrez-Fernández J, Romero-Ortiz AD, Ramos-Urbina EM, Morales-García C. Jiménez-Rodríguez BM, et al. Among authors: morales garcia c. Healthcare (Basel). 2022 Nov 22;10(12):2341. doi: 10.3390/healthcare10122341. Healthcare (Basel). 2022. PMID: 36553867 Free PMC article.
Impact of Anti-IL5 Therapies on Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study.
Rojo-Tolosa S, González-Gutiérrez MV, Jiménez-Gálvez G, Sánchez-Martínez JA, Pineda-Lancheros LE, Gálvez-Navas JM, Jiménez-Morales A, Pérez-Ramírez C, Morales-García C. Rojo-Tolosa S, et al. Among authors: morales garcia c. Int J Mol Sci. 2023 Jan 19;24(3):2011. doi: 10.3390/ijms24032011. Int J Mol Sci. 2023. PMID: 36768331 Free PMC article.
Impact of Exposome Factors on Epidermal Barrier Function in Patients with Obstructive Sleep Apnea Syndrome.
Romera-Vilchez M, Montero-Vilchez T, Herrero-Fernandez M, Rodriguez-Pozo JA, Jimenez-Galvez G, Morales-Garcia C, Buendia-Eisman A, Arias-Santiago S. Romera-Vilchez M, et al. Among authors: morales garcia c. Int J Environ Res Public Health. 2022 Jan 7;19(2):659. doi: 10.3390/ijerph19020659. Int J Environ Res Public Health. 2022. PMID: 35055481 Free PMC article.
Impact of Omalizumab in Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study.
Rojo-Tolosa S, González-Gutiérrez MV, Sánchez-Martínez JA, Jiménez-Gálvez G, Pineda-Lancheros LE, Gálvez-Navas JM, Jiménez-Morales A, Pérez-Ramírez C, Morales-García C. Rojo-Tolosa S, et al. Among authors: morales garcia c. Pharmaceutics. 2023 Feb 4;15(2):523. doi: 10.3390/pharmaceutics15020523. Pharmaceutics. 2023. PMID: 36839845 Free PMC article.
Concomitant tuberculosis and lung cancer diagnosed by bronchoscopy.
Morales-García C, Parra-Ruiz J, Sánchez-Martínez JA, Delgado-Martín AE, Amzouz-Amzouz A, Hernández-Quero J. Morales-García C, et al. Int J Tuberc Lung Dis. 2015 Sep;19(9):1027-32. doi: 10.5588/ijtld.14.0578. Int J Tuberc Lung Dis. 2015. PMID: 26260819
Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study.
Entrenas Costa LM, Casas-Maldonado F, Soto Campos JG, Padilla-Galo A, Levy A, Álvarez Gutiérrez FJ, Gómez-Bastero Fernández AP, Morales-García C, Gallego Domínguez R, Villegas Sánchez G, Mateos Caballero L, Pereira-Vega A, García Polo C, Pérez Chica G, Martín Villasclaras JJ. Entrenas Costa LM, et al. Pharmacoecon Open. 2019 Sep;3(3):333-342. doi: 10.1007/s41669-019-0117-4. Pharmacoecon Open. 2019. PMID: 30684255 Free PMC article.
27 results